Peptual Tesamorelin – Metabolic & Growth Hormone Signaling Support
 
Peptual Tesamorelin is a high-purity synthetic peptide designed for advanced research and laboratory applications focused on the regulation of growth hormone secretion and adipose tissue metabolism.
 
Tesamorelin is a stabilized analog of the growth hormone-releasing factor (GRF). It is extensively researched for its ability to stimulate the pituitary gland to synthesize and release endogenous growth hormone in a pulsatile manner. Unlike direct GH administration, Tesamorelin is studied for its role in maintaining natural feedback mechanisms. Research primarily focuses on its interaction with the endocrine system to address lipodystrophy, systemic metabolic flexibility, and the reduction of visceral adipose tissue (VAT).
 
This advanced 20mg formulation is commonly used in research settings exploring metabolic homeostasis, the deceleration of age-related endocrine decline, and the modulation of IGF-1 levels.
 
Ultra-High Purity: >99.5% as verified by LCMS and Mass Spectrometry analysis.
Identity Confirmed: Molecular weight verified at 5135.78 Da, ensuring precise sequence integrity.
Endotoxin Tested: Verified at 0.049 EU/mg to ensure high-standard laboratory safety and precision.
Physiological Signaling: Studied for its targeted action on pituitary somatotrophs without significantly impacting other pituitary hormones.
 
For laboratory research use only. Not for human consumption.
 
Keep in a cool, dry place. For long-term preservation of bioactive signaling properties, storage at -20°C or -80°C is recommended as per laboratory specifications. Once reconstituted, follow specific laboratory protocols for immediate use.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.